{
  "symbol": "ELV",
  "year": 2023,
  "metrics": {
    "mdna_sentiment": 0.0,
    "outlook_sentiment": 0.2841,
    "forward_ratio": 1.0,
    "hedge_ratio": 0.124
  },
  "top_positive": [
    {
      "sent": "Notes to Consolidated Financial Statements (continued) A summary of fair value measurements by level for assets and liabilities measured at fair value on a recurring basis at December\u00a031, 2022 and 2021 is as follows: Level I Level II Level\u00a0III Total December 31, 2022 Assets: Cash equivalents $ 3,567 $ \u2014 $ \u2014 $ 3,567 Fixed maturity securities, available-for-sale: United States Government securities \u2014 1,401 \u2014 1,401 Government sponsored securities \u2014 78 \u2014 78 Foreign government securities \u2014 274 \u2014 274 States, municipalities and political subdivisions, tax-exempt \u2014 4,143 \u2014 4,143 Corporate securities \u2014 12,392 137 12,529 Residential mortgage-backed securities \u2014 2,663 \u2014 2,663 Commercial mortgage-backed securities \u2014 1,878 \u2014 1,878 Other asset-backed securities \u2014 3,382 356 3,738 Total fixed maturity securities, available-for-sale \u2014 26,211 493 26,704 Equity securities: Exchange traded funds 822 \u2014 \u2014 822 Common equity securities 2 41 \u2014 43 Private equity securities \u2014 \u2014 88 88 Total equity securities 824 41 88 953 Other invested assets - common equity securities 103 \u2014 \u2014 103 Securities lending collateral \u2014 2,457 \u2014 2,457 Derivatives - other assets \u2014 3 \u2014 3 Total assets $ 4,494 $ 28,712 $ 581 $ 33,787 Liabilities: Derivatives - other liabilities $ \u2014 $ ( 60 ) $ \u2014 $ ( 60 ) Total liabilities $ \u2014 $ ( 60 ) $ \u2014 $ ( 60 ) December 31, 2021 Assets: Cash equivalents $ 2,415 $ \u2014 $ \u2014 $ 2,415 Fixed maturity securities, available-for-sale: United States Government securities \u2014 1,432 \u2014 1,432 Government sponsored securities \u2014 68 \u2014 68 Foreign government securities \u2014 347 \u2014 347 States, municipalities and political subdivisions, tax-exempt \u2014 5,621 \u2014 5,621 Corporate securities \u2014 12,027 336 12,363 Residential mortgage-backed securities \u2014 2,513 5 2,518 Commercial mortgage-backed securities \u2014 1,643 \u2014 1,643 Other asset-backed securities \u2014 2,888 19 2,907 Total fixed maturity securities, available-for-sale \u2014 26,539 360 26,899 Equity securities: Exchange traded funds 1,750 \u2014 \u2014 1,750 Common equity securities 8 34 \u2014 42 Private equity securities \u2014 \u2014 89 89 Total equity securities 1,758 34 89 1,881 Other invested assets - common equity securities 138 \u2014 \u2014 138 Securities lending collateral \u2014 2,155 \u2014 2,155 Derivatives - other assets \u2014 19 \u2014 19 Total assets $ 4,311 $ 28,747 $ 449 $ 33,507 Liabilities: Derivatives - other liabilities $ \u2014 $ ( 1 ) $ \u2014 $ ( 1 ) Total liabilities $ \u2014 $ ( 1 ) $ \u2014 $ ( 1 ) -96- Elevance Health, Inc.",
      "score": 0.9964
    },
    {
      "sent": "A summary of our outstanding fair value hedges at December\u00a031, 2022 and 2021 is as follows: Type of Fair Value Hedges Year Entered Into Outstanding\u00a0Notional\u00a0Amount Interest Rate Received Expiration Date 2022 2021 Interest rate swap 2022 $ 150 $ \u2014 5.500 % April 15, 2032 Interest rate swap 2022 75 \u2014 4.101 September 1, 2027 Interest rate swap 2022 75 \u2014 2.250 November 15, 2029 Interest rate swap 2021 150 150 2.550 September 15, 2030 Interest rate swap 2021 100 100 2.250 November 15, 2029 Interest rate swap 2020 75 75 4.101 September 1, 2027 Interest rate swap 2018 50 50 4.101 September 1, 2027 Interest rate swap 2018 450 450 3.300 January 15, 2023 Total notional amount outstanding $ 1,125 $ 825 The following amounts were recorded on our consolidated balance sheets related to cumulative basis adjustments for fair value hedges at December\u00a031, 2022 and 2021: Balance Sheet Classification in Which Hedged Item is Included Carrying Amount of Hedged Liability Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Liability 2022 2021 2022 2021 Long-term debt $ 22,349 $ 21,157 $ ( 57 ) $ 18 Cash Flow Hedges We have entered into a series of forward starting pay fixed interest rate swaps with the objective of eliminating the variability of cash flows in the interest payments on future financings that were anticipated at the time of entering into the swaps.",
      "score": 0.9949
    },
    {
      "sent": "Accumulated Other Comprehensive (Loss) Income A reconciliation of the components of accumulated other comprehensive (loss) income at December\u00a031, 2022, 2021, and 2020 is as follows: 2022 2021 2020 Net unrealized investment gains: Beginning of year balance $ 492 $ 949 $ 521 Other comprehensive (loss) income before reclassifications, net of tax benefit (expense) of $ 926 , $ 121 , and $( 160 ), respectively ( 2,614 ) ( 357 ) 478 Amounts reclassified from accumulated other comprehensive income, net of tax benefit (expense) of $( 94 ), $ 27 , and $( 13 ), respectively 354 ( 100 ) ( 50 ) Other comprehensive (loss) income ( 2,260 ) ( 457 ) 428 End of year balance ( 1,768 ) 492 949 Non-credit components of impairments on investments: Beginning of year balance \u2014 ( 2 ) ( 2 ) Other comprehensive income, net of tax (expense) benefit of $ 0 , $( 1 ),and $ 0 , respectively ( 3 ) 2 \u2014 End of year balance ( 3 ) \u2014 ( 2 ) Net cash flow hedges: Beginning of year balance ( 239 ) ( 250 ) ( 262 ) Other comprehensive income, net of tax expense of $( 6 ), $( 3 ), and $( 3 ), respectively 10 11 12 End of year balance ( 229 ) ( 239 ) ( 250 ) Pension and other postretirement benefits: Beginning of year balance ( 429 ) ( 552 ) ( 551 ) Other comprehensive income (loss), net of tax expense of $( 23 ), $( 36 ), and $( 2 ), respectively ( 70 ) 123 ( 1 ) End of year balance ( 499 ) ( 429 ) ( 552 ) Foreign currency translation adjustments: Beginning of year balance ( 4 ) 5 ( 2 ) Other comprehensive (loss) income, net of tax benefit (expense) of $ 6 , $ 2 , and $( 2 ) ( 13 ) ( 9 ) 7 End of year balance ( 17 ) ( 4 ) 5 Total: Total beginning of year accumulated other comprehensive (loss) income ( 178 ) 150 ( 296 ) Total other comprehensive (loss) income, net of tax benefit (expense) of $ 809 , $ 110 , and $( 154 ), respectively ( 2,336 ) ( 330 ) 446 Total other comprehensive loss attributable to noncontrolling interests, net of tax (expense) benefit of $( 3 ), $ 1 , and $ 0 , respectively 11 2 \u2014 Total end of year accumulated other comprehensive (loss) income $ ( 2,503 ) $ ( 178 ) $ 150 -129- Elevance Health, Inc.",
      "score": 0.9947
    }
  ],
  "top_negative": [
    {
      "sent": "A new pandemic or other large-scale medical emergency or public health crisis, referred to collectively as \u201cpublic health crises,\u201d may cause illness, death, quarantines, business and school shutdowns, reductions in business activity, travel and financial transactions, unemployment, inflation, labor shortages, supply chain interruptions and overall economic and financial market instability.",
      "score": -0.9612
    },
    {
      "sent": "-35- GENERAL RISKS We also face other risks that could adversely affect our business, financial condition or results of operations, which include: \u2022 adverse securities and credit market conditions, which could impact our ability to meet liquidity needs; \u2022 any requirement to restate financial results in the event of inappropriate application of accounting principles; \u2022 changes in tax laws and regulations or changes in the interpretation of tax laws and regulations by governmental authorities that could impact the future value of our deferred tax assets and deferred tax liabilities, or result in significant one-time charges in the current or future taxable years; \u2022 a significant failure of our internal control over financial reporting; \u2022 failure of our prevention and control systems related to employee compliance with internal policies, including data security and data privacy; \u2022 provider fraud that is not prevented or detected and impacts our medical costs or those of self-insured customers; \u2022 failure to protect our proprietary information and other sensitive data; and \u2022 failure of our corporate governance policies or procedures.",
      "score": -0.9083
    },
    {
      "sent": "Additionally, other extreme events such as natural disasters, war, terrorism and civil unrest could create public health crises or otherwise have a material adverse effect on our business, cash flows, financial condition and results of operations.",
      "score": -0.9001
    }
  ],
  "forward_snippets": [
    "We believe in working together to achieve our mission of improving lives and communities, simplifying healthcare and expecting more.",
    "We believe in working together to achieve our mission of improving lives and communities, simplifying healthcare and expecting more.",
    "-3- As part of our name change to Elevance Health, in June 2022, we announced that over the next several years we will organize our brand portfolio into the following core go-to-market brands: \u2022 Anthem Blue Cross/Anthem Blue Cross and Blue Shield \u2014 represents our existing Anthem-branded and affiliated Blue Cross and/or Blue Shield licensed plans; \u2022 Wellpoint \u2014 we intend to unite select non-BCBSA licensed Medicare, Medicaid and Commercial plans under the Wellpoint name; and \u2022 Carelon \u2014 this brand brings together \n the health benefits industry in general or us in particular; events that may negatively affect our licenses with the Blue Cross and Blue Shield Association; intense competition to attract and retain employees; risks associated with our international operations; and various laws and provisions in our governing documents that may prevent or discourage takeovers and business combinations.",
    "We believe in working together to achieve our mission of improving lives and communities, simplifying healthcare and expecting more.",
    "-3- As part of our name change to Elevance Health, in June 2022, we announced that over the next several years we will organize our brand portfolio into the following core go-to-market brands: \u2022 Anthem Blue Cross/Anthem Blue Cross and Blue Shield \u2014 represents our existing Anthem-branded and affiliated Blue Cross and/or Blue Shield licensed plans; \u2022 Wellpoint \u2014 we intend to unite select non-BCBSA licensed Medicare, Medicaid and Commercial plans under the Wellpoint name; and \u2022 Carelon \u2014 this brand brings together our healthcare-related services and capabilities, including our formerly named Diversified Business Group and IngenioRx businesses, under a single brand name."
  ]
}